By Mill Chart
Last update: Feb 26, 2024
Quality investors are looking for the best of the best. Companies which are growing steadily and consistently, but are also in excellent financial condition. We will have a look here to see if NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) is suited for quality investing. Investors should of course do their own research, but we spotted NOVO-NORDISK A/S-SPONS ADR showing up in our Caviar Cruise quality screen, so it may be worth spending some more time on it.
Every day, ChartMill assigns a Fundamental Rating to each stock, providing a score ranging from 0 to 10. This rating is determined by evaluating various fundamental indicators and properties.
Taking everything into account, NVO scores 7 out of 10 in our fundamental rating. NVO was compared to 202 industry peers in the Pharmaceuticals industry. NVO scores excellent points on both the profitability and health parts. This is a solid base for a good stock. NVO is not priced too expensively while it is growing strongly. Keep and eye on this one! NVO also has an excellent dividend rating. With these ratings, NVO could be worth investigating further for dividend and growth and quality investing!.
Check the latest full fundamental report of NVO for a complete fundamental analysis.
More ideas for quality investing can be found on ChartMill in our Caviar Cruise screen.
This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.
69.02
+0.51 (+0.74%)
Find more stocks in the Stock Screener
NOVO-NORDISK (NYSE:NVO) offers strong growth, high profitability, and reasonable valuation, making it an attractive candidate for investors seeking affordable growth stocks.
NOVO-NORDISK A/S (NYSE:NVO) is a strong value stock with high profitability, solid growth, and an attractive valuation, making it a candidate for long-term investors.